Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies

Background: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and the UK confirm the vulnerability of HM patients to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahimainathan, Lenin, Narasimhan, Madhusudhanan, Corchado, Rolando, Patel, Hetalkumari, Kansagra, Ankit, Devaraj, Sridevi, Geethakumari, Praveen Ramakrishnan, Muthukumar, Alagarraju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760559/
https://www.ncbi.nlm.nih.gov/pubmed/33255154
http://dx.doi.org/10.3390/diagnostics10120992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760559/
https://www.ncbi.nlm.nih.gov/pubmed/33255154
http://dx.doi.org/10.3390/diagnostics10120992

Ejemplares similares